Figure 10.Change from Baseline (%) in BMI in Pediatric Patients with Obesity Aged 12 Years and Older in Study 7 Observed values for patients completing each scheduled visit, and estimates with multiple imputations from retrieved dropouts (RD-MI) Figure 11.Change in BMI (%) from Baseline to Week 68 in Pediatric Patients with Obesity Aged 12 Years and Older in Study 7 Observed data from in-trial period including imputed data for missing observations (RD-MI) Effect of WEGOVY on Anthropometry and Cardiometabolic Parameters in Pediatric Patients with Obesity Aged 12 Years and Older Changes in waist circumference and cardiometabolic parameters with WEGOVY are shown in Table 14 for the study in pediatric patients aged 12 years and older

To help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation, it is expected that Judge Pratter will establish a bellwether process to prepare a small group of Ozempic or Wegovy lawsuits for early trial dates
Consistency with timing and correct injection form maximizes the medication's effectiveness and reduces injection-site discomfort or bruising
Retrieved from Kennedy, C., Hayes, P., Salama, S., et al
As a human person, Im not sure